Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

被引：0
|
作者：
D A Reardon
A Desjardins
J J Vredenburgh
S Gururangan
J H Sampson
S Sathornsumetee
R E McLendon
J E Herndon
J E Marcello
J Norfleet
A H Friedman
D D Bigner
H S Friedman
机构：
[1] The Preston Robert Tisch Brain Tumor Center,Department of Surgery
[2] Duke University Medical Center,Department of Pediatrics
[3] The Preston Robert Tisch Brain Tumor Center,Department of Medicine
[4] Duke University Medical Center,Department of Pathology
[5] The Preston Robert Tisch Brain Tumor Center,undefined
[6] Duke University Medical Center,undefined
[7] The Preston Robert Tisch Brain Tumor Center,undefined
[8] Duke University Medical Center,undefined
[9] Cancer Center Biostatistics,undefined
[10] The Preston Robert Tisch Brain Tumor Center,undefined
[11] Duke University Medical Center,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
malignant glioma; glioblastoma; angiogenesis; bevacizumab; vascular endothelial growth factor; metronomic chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1986 / 1994
页数：8
相关论文
共 50 条
  • [21] Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Dowel, Jeannette M.
    Reardon, David A.
    Quinn, Jennifer A.
    Rich, Jeremy N.
    Sathornsumetee, Sith
    Gururangan, Sridharan
    Wagner, Melissa
    Bigner, Darell D.
    Friedman, Allan H.
    Friedman, Henry S.
    CLINICAL CANCER RESEARCH, 2007, 13 (04) : 1253 - 1259
  • [22] Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients
    Correale, Pierpaolo
    Botta, Cirino
    Basile, Assunta
    Pagliuchi, Marco
    Licchetta, Antonella
    Martellucci, Ignazio
    Bestoso, Elena
    Apollinari, Serena
    Addeo, Raffaele
    Misso, Gabriella
    Romano, Ornella
    Abbruzzese, Alberto
    Lamberti, Monica
    Luzzi, Luca
    Gotti, Giuseppe
    Rotundo, Maria Saveria
    Caraglia, Michele
    Tagliaferri, Pierosandro
    CANCER BIOLOGY & THERAPY, 2011, 12 (02) : 112 - 118
  • [23] BEVACIZUMAB AND NITROSOUREA IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE II MULTICENTER ITALIAN STUDY
    Ruda, Roberta
    Trevisan, Elisa
    Picco, Elisabetta
    Guarneri, Daniele
    Caroli, Manuela
    Fabrini, Maria G.
    Scotti, Valerio
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2009, 11 (06) : 905 - 905
  • [24] Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma
    Korones, DN
    Benita-Weiss, M
    Coyle, TE
    Mechtler, L
    Bushunow, P
    Evans, B
    Reardon, DA
    Quinn, JA
    Friedman, H
    CANCER, 2003, 97 (08) : 1963 - 1968
  • [25] Phase II study of bevacizumab and nitrosourea in patients with recurrent malignant glioma: A multicenter Italian study
    Soffietti, R.
    Ruda, R.
    Trevisan, E.
    Picco, E.
    Guarneri, D.
    Caroli, M.
    Fabrini, M.
    Scotti, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    McLendon, Roger E.
    Marcello, Jennifer
    Herndon, James E.
    Mathe, Alyssa
    Hamilton, Marta
    Rich, Jeremy N.
    Norfleet, Julie A.
    Gururangan, Sridharan
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2010, 12 (12) : 1300 - 1310
  • [27] Bevacizumab versus bevacizumab plus vorinostat in adults with recurrent malignant glioma: Results of a phase I part of a phase I/II trial
    Wu, Jing
    Groves, Morris D.
    Gilbert, Mark R.
    Hess, Kenneth R.
    Loch, Carolyn Sue
    Ictech, Sandra
    De Groot, John Frederick
    Conrad, Charles A.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Treatment With Bevacizumab Plus Carboplatin for Recurrent Malignant Glioma
    Thompson, Eric M.
    Dosa, Edit
    Kraemer, Dale F.
    Neuwelt, Edward A.
    NEUROSURGERY, 2010, 67 (01) : 87 - 93
  • [29] BEVACIZUMAB PLUS TEMOZOLOMIDE FOR RECURRENT MALIGNANT GLIOMA: UPDATE
    Badruddoja, Michael A.
    NEURO-ONCOLOGY, 2009, 11 (05) : 631 - 631
  • [30] Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma
    Affronti, Mary Lou
    Jackman, Jennifer Gamboa
    McSherry, Frances
    Herndon, James E., II
    Massey, Elwood C., Jr.
    Lipp, Eric
    Desjardins, Annick
    Friedman, Henry S.
    Vlahovic, Gordana
    Vredenburgh, James
    Peters, Katherine B.
    ONCOLOGIST, 2018, 23 (08): : 889 - +
12345